FDA signals support for Pfizer’s RSV shot in adcomm docs before crucial vote
The FDA released briefing documents on Tuesday describing Pfizer’s RSV vaccine as effective at preventing severe disease with a “generally favorable …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
